← Back
$AGIO All transactions

AGIOS PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$140K

Shares

4,091

Price

$34

Filed

Jul 3

Insider

Name

Gheuens Sarah

Title

Chief Medical Officer

CIK

0001881190

Roles

Officer

Transaction Details

Transaction Date

2025-07-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

61,271

Footnotes

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated July 1, 2023. | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. | The restricted stock units were granted on July 1, 2023. Beginning on July 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.

Filing Info

Accession No.

0001439222-25-000073

Form Type

4

Issuer CIK

0001439222

Gheuens Sarah's History

Date Ticker Type Value
2026-04-02 AGIO M $0
2026-04-02 AGIO $102K
2026-04-02 AGIO M $0
2025-12-30 AGIO M $0
2025-12-30 AGIO $79K
2025-12-30 AGIO M $0
2025-11-11 AGIO M $61K
2025-11-11 AGIO $107K
2025-11-11 AGIO M $0
2025-10-30 AGIO M $5K

Other Insiders at AGIO (90d)

Insider Bought Sold Last
Goff Brian
Chief Executive Officer
$662K 2026-04-02
Jones Cecilia
Chief Financial Officer
$109K 2026-04-02
Gheuens Sarah
Chief Medical Officer
$102K 2026-04-02
Burns James William
Chief Legal Officer
$114K 2026-04-02
Milanova Tsveta
Chief Commercial Officer
$113K 2026-04-02
Viswanadhan Krishnan
Chief Corp Dev & Strategy
$103K 2026-04-02